WisdomTree US Equity Income ETF
23,06
EUR
+0,26
EUR
+1,13
%
NAV
Werbung
Werbung
WisdomTree US Equity Income ETF Kurs - 1 Jahr
Kein Chart verfügbar.
| Emittent | WisdomTree Management |
| Auflagedatum | 07.11.2016 |
| Kategorie | Aktien |
| Fondswährung | EUR |
| Benchmark | WisdomTree US Equity Income UCITS |
| Ausschüttungsart | Thesaurierend |
| Total Expense Ratio (TER) | 0,35 % |
| Fondsgröße | 100.622.564,96 |
| Replikationsart | Physisch optimiert |
| Morningstar Rating | - |
Anlageziel WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc
So investiert der WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc: The Fund seeks to track the price and yield performance, before fees and expenses, of an index that measures the performance of US securities. In order to achieve this objective, the Fund will employ a "passive management" (or indexing) investment approach and will invest in a portfolio of equity securities that so far as possible and practicable consists of a representative sample of the component securities of the WisdomTree US Equity Income UCITS Index (the “Index”).
Der WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2AS9T
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2024 | |
|---|---|---|---|---|---|---|
| Performance | +0,07 % | +11,65 % | +12,69 % | +15,65 % | +28,31 % | +12,87 % |
| Outperformance ggü. Kategorie | +0,91 % | +10,68 % | +4,83 % | +11,11 % | -4,09 % | +3,90 % |
| Max Verlust | - | - | -5,54 % | -23,97 % | -28,35 % | - |
| Kurs | - | - | - | - | - | 23,06 € |
| Hoch | - | - | 24,79 € | - | - | - |
| Tief | - | - | 19,26 € | - | - | - |
Kennzahlen ISIN: DE000A2AS9T2
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | 12,42 % | 16,94 % | 18,13 % | |
| Sharpe Ratio | +1,89 | +0,49 | +0,41 |
Zusammensetzung WKN: A2AS9T
Größte Positionen ISIN: DE000A2AS9T2
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| AbbVie Inc | US00287Y1091 | 297.967.924.710 € | 5,23 % |
| Johnson & Johnson | US4781601046 | 334.033.419.764 € | 5,05 % |
| PepsiCo Inc | US7134481081 | 201.311.821.761 € | 4,96 % |
| Exxon Mobil Corp | US30231G1022 | 446.852.972.246 € | 4,87 % |
| Merck & Co Inc | US58933Y1055 | 238.193.604.149 € | 3,79 % |
| AT&T Inc | US00206R1023 | 156.763.660.809 € | 3,68 % |
| Chevron Corp | US1667641005 | 246.532.219.341 € | 3,50 % |
| International Business Machines Corp | US4592001014 | 198.337.654.855 € | 2,89 % |
| Gilead Sciences Inc | US3755581036 | 110.791.318.544 € | 2,88 % |
| Morgan Stanley | US6174464486 | 190.979.544.800 € | 2,62 % |
| Summe Top 10 | 39,47 % | ||